Intraoperative Neuromonitoring Market Share Analysis of The Top Industry Players, Growth Opportunities and Country Level Segments
The growth in the market will be led by the ageing
population, increasing prevalence of chronic disorders, applications of IONM in
different surgeries, and risk management through IONM during complex surgeries.
In terms of product and services, the intraoperative
neuromonitoring market has been categorized into systems, instruments,
and accessories. The systems segment was the largest contributor to the global
market, with more than 45% share in 2016.
The global intraoperative neuromonitoring market for
brainstem auditory evoked potentials (BAEPs) is expected to witness the fastest
growth in demand, registering a CAGR in of around 8% during the forecast
period. The other IONM modalities include somatosensory evoked potentials
(SSEPs), motor evoked potentials (MEPs), electromyography (EMG), electroencephalography
(EEG), and visual evoked potentials (VEPs).
Request to Get the Sample Pages at:
The IONM applications involve spinal surgery, neurosurgery,
vascular surgery, ENT surgery, orthopedic surgery, and other surgeries. Among
the available applications of IONM, orthopedic surgery is estimated to witness
the fastest growth in demand at a CAGR of 7.9% during the forecast period. By end
user, the intraoperative neuromonitoring market is led by hospitals
contributing more than $2 billion in 2016. The large number of hospitals is the
major factor to its large share in the market.
Asia-Pacific is the potential intraoperative
neuromonitoring market for the growth of due to the high population
base, presence of unmet medical needs, and increasing disposable incomes of
people in the region. Moreover, the medical tourism and technological
advancements make Asia-Pacific a lucrative market for IONM. It is estimated
that the APAC will witness the fastest growth in demand at a CAGR of 8.6%
during the forecast period.
Key players in the intraoperative neuromonitoring industry
are launching advanced products, to gain a larger market share. For instance,
in February 2016, Nihon Kohden Corporation launched Neuromaster MEE-2000A, an
IONM system, used in spine, neurology, vascular orthopedic, and otolaryngologic
procedures. Similarly, in October 2016, Modberg Research Inc., launched CNS 300
monitor with wide screen display, high resolution, and advanced ICU amplifier.
Some of the other key players operating in the global
intraoperative neuromonitoring market are Accurate Monitoring LLC,
Computational Diagnostics, Inc., IntraNerve, LLC, Inomed Medizintechnik GmbH,
Medtronic plc, and SpecialtyCare.
Comments
Post a Comment